Biotech Crystal Growth in Microgravity

India may soon be making medicines in space. A company called Serendipity Space is developing a system to manufacture pharmaceuticals in orbit. Biotech companies are developing orbital drug factories to exploit the unique properties of microgravity. The process, called microgravity crystallization, involves growing proteins that would normally be flawed on Earth. Unlike the Earth's gravity, which pulls molecules downward and messes up the structure, the lack of gravity in orbit allows molecules to float freely and form perfect crystals.

Cosmic Compounds: Growing Crystals in Microgravity

Microgravity crystallization is a method for manufacturing pharmaceuticals in orbit. In this process, crystals grow in an environment devoid of Earths gravity. The crystallization process begins with a protein or a complex medical compound. These molecules attempt to stack themselves into a solid crystal structure, which is essential for a cutting-edge drug. However, Earth's constant downward gravity actively forces the heavier pieces downward, preventing an orderly arrangement. Microgravity changes the equation. In the orbit, the downward force vanishes. The molecules float freely, bonding with perfectly uniform spacing in every single direction. This would not be possible on Earth, which has active forces like gravity. Therefore, Serendipity Space built a fully autonomous orbital laboratory to achieve flawless weightless assembly without sending a single astronaut. This process unlocks medical formulations that, until now, were impossible to create on Earth. The process starts with a fully autonomous uncrewed system designed to capture this flawless crystal growth in space. After the crystal growth finishes, robotic systems seal it inside a heavy-duty heat shield. This shield protects the sample from the extreme conditions during the violent deceleration of atmospheric reentry.

New Space Economy?

The idea of biotech factories in orbit is gaining traction, with Serendipity Space leading the charge. Space-based pharmaceutical manufacturing could revolutionize medicine by producing high-quality drugs. Healthcare and space technologies are two industries with massive potential for growth. Microgravity crystallization can revolutionize the medicine-making process. Innovations in space technology have given birth to new ideas such as in-orbit drug factories and on-demand manufacturing. If Serendipity Space's ambitious project succeeds, it could pave the way for other Indian space manufacturing ventures. India's pharmaceutical industry will gain from this innovation, allowing them to get access to medicines that were once thought to be impossible. However, the startup still faces significant challenges, including orbital testing, pharmaceutical validation, regulatory approval, and economics.

The Autonomous Lab

How crystals grow in orbit

Inside the orbital laboratory, the lack of gravity makes it possible for molecules to float freely and bond perfectly. Robotic systems are also used to manage the entire process. After the crystal growth process finishes, these robotic systems seal it inside a heavy-duty heat shield for the violent deceleration of atmospheric reentry. A fully autonomous system is a key part of biotech manufacturing in orbit. The lab's autonomous systems start the crystallization process after launch. The crystal growth continues continuously as the lab rotates around the planet. It requires no human intervention, which is essential for such delicate processes. The elimination of human presence could significantly reduce the chances of errors. These characteristics make the lab an ideal platform for growing crystals in orbit.

Space Research

Researchers have long been aware of the benefits of growing crystals in space. While the method was known, it faced the hurdle of high cost. However, the growth of private space companies and falling launch costs has made space manufacturing a viable option. This unique process would allow the use of space beyond the exploration of planets and galaxies. Scientists could use it to unlock new potential for pharmaceutical compounds that would otherwise be impossible to produce on Earth.

Medications in Microgravity

Molecules like proteins are fundamental to medicine. Crystals made of these molecules are essential for a wide range of drugs. However, the Earth’s gravity can make the crystals defective, limiting the drug's effectiveness. Moreover, the process also reduces the quality of the final product. Molecules behave differently in microgravity. The process relies on the absence of gravity, which provides the crystal growth process with the perfect environment. It eliminates any occurrences that could ruin the final product. However, it doesn't mean that crystals will grow perfectly every time. But the chances of growing defective crystals will be much lower, improving the quality of the drug.

How to Trust Medicine Made in Space

Serendipity Space has already conducted a high-altitude balloon test, taking the company a step closer to reaching its goal. The company intends to use microgravity to improve the process of pharmaceutical manufacturing. But before commercializing biotech in orbit, the startup has some challenges to face. It needs to demonstrate that it can successfully grow crystals in orbit, ensure that the process can be scaled up, and secure regulatory approval. Additionally, the economics of such a venture still remains ambiguous. Still, it remains confident about the idea. After all, drug manufacturing in space could revolutionize the way medicines are made.

Space-bound Drugs?

Space travel can be exciting, and many are wondering if space-bound drugs are too. The idea of life-saving drugs manufactured in space sounds fascinating, but it still needs to overcome several obstacles. One of the biggest concerns people have about the idea is whether they should trust medicines manufactured in space. The main issues are linked to the economic cost of the production and the quality of the drugs and their certification. Even manufacturing a drug in space can challenge conventional certifications. Any drug produced by orbital technology should meet the same standards as those produced in labs to avoid health risks. But if Serendipity Space can overcome the issues regarding certification, it could usher in an era of low-gravity pharmaceuticals.

Reaping the Harvest: When Will We See Space Drugs?

In February 2023, Serendipity Space tested its autonomous manufacturing system on a high-altitude balloon. It is a significant milestone for the startup, as it tests the prototype in space-like conditions. The next step for Serendipity Space is to successfully validate that it can perform the manufacturing process continuously in low Earth orbit. Space is full of uncertainties, making it hard to predict the exact timeline. However, Serendipity Space's success could revolutionize the way medicines are manufactured.